Entrada Therapeutics Reports Third Quarter 2021 Financial Results

Go back to Entrada Therapeutics Reports Third Quarter 2021 Financial Results
(NASDAQ: TRDA) Delayed: 7.27 -0.05 (0.68%)
Previous Close $7.32    52 Week High
Open $7.21    52 Week Low
Day High $7.43    P/E N/A 
Day Low $7.16    EPS
Volume 129,755